Top brokers name 3 ASX shares to sell today

Brokers are bearish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday, we looked at three ASX shares that brokers have given buy ratings to this week. Unfortunately, not all shares are in favour with brokers right now.

Three ASX shares that have just been given sell ratings by brokers are listed below. Here's why they are bearish on them:

ASX Ltd (ASX: ASX)

According to a note out of Morgan Stanley, its analysts have retained their underweight rating and $74.00 price target on this stock exchange operator's shares. This follows the announcement that its CHESS replacement project has been delayed from its April 2023 go-live target date. While the broker was expecting such a delay, it warned that this could mean operating costs will be higher for longer. It also sees risks for write downs on its prior investment expenditure if it has to switch approach. The ASX share price is trading at $81.92 on Friday.

Commonwealth Bank of Australia (ASX: CBA)

A note out of Macquarie reveals that its analysts have retained their underperform rating and $90.00 price target on this banking giant's shares. Macquarie suspects that CBA could struggle to outperform its rivals in respect to revenue growth in the coming years due partly to sustained mortgage competition. In light of this, it feels the company's shares don't warrant their premium valuation. The CBA share price is fetching $101.98 this afternoon.

Insurance Australia Group Ltd (ASX: IAG)

Another note out of Morgan Stanley reveals that its analysts have retained their underweight rating and $4.05 price target on this insurance company's shares. While Morgan Stanley sees rising interest rates as a positive for IAG, it appears to believe it is too soon to get excited. Especially given how inclement weather could lead to higher claims. The IAG share price is trading at $4.62 today.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

Read more »

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »